You are here

  • Home
  • Archive
  • Volume 21, Issue 1
  • Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches

Article metrics

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches

 

Online download statistics by month:

Online download statistics by month: December 2015 to March 2024

AbstractFullPdf
Dec 20154737
Jan 20162311626
Feb 2016110519
Mar 20161211633
Apr 201652718
May 20166088
Jun 20164356
Jul 20162634
Aug 20162532
Sep 20162312
Oct 201632710
Nov 2016271015
Dec 20163043
Jan 20173267
Feb 20172733
Mar 20174074
Apr 201735114
May 20172774
Jun 20175022
Jul 20175221
Aug 20176921
Sep 20174611
Oct 201782117
Nov 201793107
Dec 20174600
Jan 20186120
Feb 20186010
Mar 201882137
Apr 20185342
May 20186132
Jun 20188651
Jul 20189611
Aug 20186133
Sep 20184561
Oct 201813252
Nov 20187400
Dec 20186410
Jan 20196911
Feb 20199141
Mar 20199460
Apr 20199011
May 20193000
Jun 20193520
Jul 20193410
Aug 20193831
Sep 20194102
Oct 20196521
Nov 20195521
Dec 20193000
Jan 20207300
Feb 20203720
Mar 20203031
Apr 20201211
May 20202821
Jun 20202111
Jul 20202111
Aug 20202943
Sep 20204620
Oct 20202521
Nov 20202120
Dec 20203412
Jan 20212000
Feb 20213800
Mar 20212800
Apr 20212310
May 2021700
Jun 2021100
Jul 2021221
Aug 2021110
Sep 2021100
Oct 20211510
Nov 20213411
Dec 20214630
Jan 20223560
Feb 20222700
Mar 20223500
Apr 20222410
May 20225743
Jun 20225710
Jul 20223140
Aug 20227320
Sep 20225300
Oct 20225800
Nov 20223721
Dec 20226700
Jan 20233310
Feb 202313930
Mar 20231200
Apr 20233720
May 20233911
Jun 20231700
Jul 20232000
Aug 20234720
Sep 20232111
Oct 20234300
Nov 20234100
Dec 20233510
Jan 20243621
Feb 2024900
Mar 20244510
Total4694280241